Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: Role of p53 inactivation

Virology

Volumn 237, Issue 2, 1997, Pages 296-306

  Sherman, Levana ^a   Jackman, Anna ^a   Itzhaki, Hagar ^a   Stöppler, Melissa Conrad ^b   Koval, Debbie ^b   Schlegel, Richard ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ONCOPROTEIN; PROTEIN P53;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030726064     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8778     Document Type: Article

References (40)

1. Baker S. J., Markowitz S., Fearon E. R., Willson J. K. V., Vogelstein B. Suppression of human colorectal carcinoma cell line growth by wild type p53. Science. 249:1990;1912-1915.
2. Band V., Dalal S., Delmolino L., Androphy E. J. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO J. 12:1993;1847-1852.
3. Barbosa M. S., Lowy D. R., Schiller J. T. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J. Virol. 63:1989;1404-1407.
4. Chellapan S., Kraus V., Kroger B., Munger K., Howley P. M., Phelps W. C., Nevins J. R. Adenovirus E1A, simian virus 40 tumor antigen and human papillomavirus E7 proteins share the capacity to disrupt the interaction between the transcription factor E2F and retinoblastoma gene product. Proc. Natl. Acad. Sci. USA. 89:1992;4549-4553.
5. Chen J. J., Reid C. E., Band V., Androphy E. J. Interaction of papillomavirus E6 oncoprotein with a putative calcium-binding protein. Science. 269:1995;529-531.
6. Stöppler M. Conrad, Ching K., Stöppler H., Clancy K., Schlegel R., Icenogle J. Natural variants of human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70:1996;6987-6993.
7. Crook T., Tidy J. A., Vousden K. H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and transactivation. Cell. 67:1991;547-556.
8. Crook T., Fisher C., Masterson P., Vousden K. H. Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene. 9:1994;1225-1230.
9. Dalal S., Gao Q., Androphy E. S., Band V. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Virol. 70:1996;683-688.
10. Davies R., Hicks R., Crook T., Morris J., Vousden K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67:1993;2521-2528.
11. Dyson N., Howley P. M., Munger K., Harlow E. The human papillomavirus 16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science. 243:1989;934-937.
12. Foster S. A., Demers G. W., Etscheid B. G., Galloway D. A. The ability of human papillomavirus E6 protein to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:1994;5698-5705.
13. Gao Q., Hauser S. H., Liu X-L., Wazer D. E., Madoc-Jones H., Band V. Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res. 56:1996;3129-3133.
14. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicolacetyl-transferase in mammalian cells. Mol. Cell Biol. 2:1982;1044-1051.
15. Halbert C. L., Demers G. W., Galloway D. A. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:1992;2125-2134.
16. Hawley-Nelson P., Vousden K. H., Hubbert N. L., Lowy D. R., Schiller J. T. HPV-16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:1989;3905-3910.
17. Hubbert N. L., Sedman S. A., Schiller J. T. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J. Virol. 66:1992;6237-6241.
18. Hudson J. B., Bedell M. A., McCance D. J., Laimins L. A. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:1990;519-526.
19. Huibregtse J. M., Scheffner M., Howley P. M. A cellular protein mediates association of p53 with E6 onocoprotein of human papillomavirus types 16 or 18. EMBO J. 10:1991;4129-4135.
20. Huibregtse J. M., Scheffner M., Howley P. M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:1993;775-784.
21. Kanda T., Watanabe S., Zanma S., Sato H., Furuno A., Yoshiike K. Human papillomavirus type 16 E6 protein with glycine substitution for cysteine in the metal-binding motif. Virology. 185:1991;536-548.
22. Keen N., Elston R., Crawford L. Interaction of the E6 protein of human papillomavirus with cellular proteins. Oncogene. 9:1994;1493-1499.
23. Kern S. E., Pietenpol J. A., Thiagalingam S., Seymour A., Kinzler K. W., Vogelstein B. Science. 256:1992;827-830.
24. Lechner M. S., Mack D. H., Finicle A. B., Crook T., Vousden K. H., Laimins L. A. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53 mediated repression of transactivation. EMBO J. 11:1992;3045-3052.
25. Lechner M. S., Laimins L. A. Inhibition of p53 DNA binding by human papillomavirus E6 protein. J. Virol. 68:1994;4262-4273.
26. Momand J., Zambetti G. P., Olson D. C., George D., Levine A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell. 69:1992;1237-1245.
27. Munger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:1989;4417-4421.
28. Nakagawa S., Watanabae S., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Mutational analysis of human papillomavirus type 16 E6 protein: Transforming function for human cells and degradation of p53 in vitro. Virology. 212:1996;535-542.
29. Oliner J. D., Kinzler K. W., Meltzer P. S., George D. L., Vogelstein B. Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature. 358:1992;80-83.
30. Pim D., Storey A., Thomas M., Massimi P., Banks L. Mutational analysis of HPV18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalization of primary BMK cells. Oncogene. 9:1994;1869-1876.
31. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
32. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
33. Schlegel R., Phelps W. C., Zhang Y.-L., Barbosa M. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7:1988;3181-3187.
34. Sedman S. A., Hubbert N. L., Vass W. C., Lowy D. R., Schiller J. T. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated transactivation or transforming activity. J. Virol. 66:1992;4201-4208.
35. Sherman L., Schlegel R. Serum and calcium induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol. 70:1996;3269-3279.
36. Sherman L., Yaniv A., Lichtman-Pleban H., Tronick S. R., Gazit A. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeat. J. Virol. 63:1989;4925-4931.
37. Thomas M., Massimi P., Jenkins J., Banks L. HPV18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation. Oncogene. 10:1995;261-268.
38. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
39. Woodworth C. D., Cheng S., Simpson S., Hamacher L., Chow L. T., Broker T. R., Dipaolo J. A. Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene. 7:1992;619-626.
40. Zur Hausen H. Papillomaviruses as carcinomaviruses. Adv. Viral Oncol. 8:1989;1-26.